IBT
AZN icon

International Biotechnology Trust’s AstraZeneca AZN Stock Holding History

International Biotechnology Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$3.15M Buy
+23,250
New +$3.18M 1.06% 30
2023
Q2 		– Sell
-32,500
Closed -$4.51M – 65
2023
Q1 		$4.51M Hold
32,500
– – 1.26% 28
2022
Q4 		$4.41M Buy
+32,500
New +$4.08M 1.36% 24

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

International Biotechnology Trust's AZN Position: Q3 2023 in Review

International Biotechnology Trust opened a new position in AstraZeneca (AZN) in Q3 2023: 23,250 shares worth $3.15M. The stake represents 1.06% of the portfolio and ranks #30 among its holdings. This is a return to the name: International Biotechnology Trust previously reported a position in AZN as recently as Q1 2023.

International Biotechnology Trust first reported a position in AZN in Q4 2022 and has held it in 3 quarters since. The position peaked at $4.51M in Q1 2023. 1,075 funds tracked by Wall St. Rank hold AZN as of Q3 2023.

  • International Biotechnology Trust held 23,250 shares of AstraZeneca worth $3.15M as of Q3 2023.
  • AstraZeneca was a new International Biotechnology Trust position in Q3 2023.
  • AstraZeneca made up 1.06% of International Biotechnology Trust's portfolio in Q3 2023, its #30 holding.
  • International Biotechnology Trust first reported a position in AstraZeneca in Q4 2022 and has held it in 3 quarters since.
  • International Biotechnology Trust's AstraZeneca position peaked at $4.51M in Q1 2023.
  • 1,075 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2023.

Based on International Biotechnology Trust's 13F filing for Q3 2023, filed 14 Nov 2023.